Case-Report: Folfoxiri Plus Bevacizumab in “Poor-Risk” Liver-Only Metastatic Colorectal Cancer: Case Report and State-of-the-Art

Publisher: Bentham Science Publishers

ISSN: 2212-697X

Source: Clinical Cancer Drugs, Vol.1, Iss.1, 2014-01, pp. : 78-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract